메뉴 건너뛰기




Volumn 59, Issue , 2008, Pages 473-485

The challenge of hepatitis C in the HIV-infected person

Author keywords

Coinfection; HCV; Injection drug use; Liver disease

Indexed keywords

ALPHA2A INTERFERON; ANTIRETROVIRUS AGENT; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2A; RIBAVIRIN; ZIDOVUDINE;

EID: 39649113866     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.59.081906.081110     Document Type: Review
Times cited : (79)

References (58)
  • 1
    • 0037087144 scopus 로고    scopus 로고
    • Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult MDS Clinical Trials Group
    • Sherman KE, Rouster SD, Chung RT, et al. 2002. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult MDS Clinical Trials Group. Clin. Infect. Dis. 34:831-37
    • (2002) Clin. Infect. Dis , vol.34 , pp. 831-837
    • Sherman, K.E.1    Rouster, S.D.2    Chung, R.T.3
  • 2
    • 0038386036 scopus 로고    scopus 로고
    • Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the D:A:D study
    • Friis-Moller N, Weber R, Reiss P, et al. 2003. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the D:A:D study. AIDS 17:1179-93
    • (2003) AIDS , vol.17 , pp. 1179-1193
    • Friis-Moller, N.1    Weber, R.2    Reiss, P.3
  • 3
    • 0037418113 scopus 로고    scopus 로고
    • Hepatitis C in the HIV-infected person
    • Sulkowski MS, Thomas DL. 2003. Hepatitis C in the HIV-infected person. Ann. Intern. Med. 138:197-207
    • (2003) Ann. Intern. Med , vol.138 , pp. 197-207
    • Sulkowski, M.S.1    Thomas, D.L.2
  • 4
    • 0027996992 scopus 로고
    • Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study
    • Gerberding JL. 1994. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J. Infect. Dis. 170:1410-17
    • (1994) J. Infect. Dis , vol.170 , pp. 1410-1417
    • Gerberding, J.L.1
  • 5
    • 0033023854 scopus 로고    scopus 로고
    • Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection
    • Villano SA, Vlahov D, Nelson KE, et al. 1999. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29:908-14
    • (1999) Hepatology , vol.29 , pp. 908-914
    • Villano, S.A.1    Vlahov, D.2    Nelson, K.E.3
  • 6
    • 28944432316 scopus 로고    scopus 로고
    • Clinical presentation and course of acute hepatitis C infection in HIV-infected patients
    • Luetkemeyer A, Hare CB, Stansell J, et al. 2006. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir. Immune Defic. Syndr. 41:31-36
    • (2006) J Acquir. Immune Defic. Syndr , vol.41 , pp. 31-36
    • Luetkemeyer, A.1    Hare, C.B.2    Stansell, J.3
  • 7
    • 34247605911 scopus 로고    scopus 로고
    • Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours
    • Danta M, Brown D, Bhagani S, et al. 2007. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 21:983-91
    • (2007) AIDS , vol.21 , pp. 983-991
    • Danta, M.1    Brown, D.2    Bhagani, S.3
  • 9
    • 79960391970 scopus 로고    scopus 로고
    • Hepatitis C virus infection in a large cohort of homosexually active men: Independent associations with HIV-1 infection and injecting drug use but not sexual behaviour
    • Bodsworth NJ, Cunningham P, Kaldor J, et al. 1996. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour. Genitourin. Med. 72:118-22
    • (1996) Genitourin. Med , vol.72 , pp. 118-122
    • Bodsworth, N.J.1    Cunningham, P.2    Kaldor, J.3
  • 10
    • 34447539217 scopus 로고    scopus 로고
    • Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940-1990
    • Goedert JJ, Chen BE, Preiss L, et al. 2007. Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940-1990. Am. J. Epidemiol. 165:1443-53
    • (2007) Am. J. Epidemiol , vol.165 , pp. 1443-1453
    • Goedert, J.J.1    Chen, B.E.2    Preiss, L.3
  • 11
    • 0026043177 scopus 로고
    • Heterosexual cotransmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV)
    • Eyster ME, Alter HJ, Aledort LM, et al. 1991. Heterosexual cotransmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann. Intern. Med. 115:764-68
    • (1991) Ann. Intern. Med , vol.115 , pp. 764-768
    • Eyster, M.E.1    Alter, H.J.2    Aledort, L.M.3
  • 12
    • 0028801508 scopus 로고
    • Mother-to-infant transmission of hepatitis C virus
    • Zanetti AR, Tanzi E, Paccagnini S, et al. 1995. Mother-to-infant transmission of hepatitis C virus. Lancet 345:289-91
    • (1995) Lancet , vol.345 , pp. 289-291
    • Zanetti, A.R.1    Tanzi, E.2    Paccagnini, S.3
  • 13
    • 16944364046 scopus 로고    scopus 로고
    • Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers
    • Hershow RC, Riester KA, Lew J, et al. 1997. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. J. Infect. Dis. 176:414-20
    • (1997) J. Infect. Dis , vol.176 , pp. 414-420
    • Hershow, R.C.1    Riester, K.A.2    Lew, J.3
  • 14
    • 17344364927 scopus 로고    scopus 로고
    • Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers
    • Thomas DL, Villano SA, Riester KA, et al. 1998. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. J. Infect. Dis. 177:1480-88
    • (1998) J. Infect. Dis , vol.177 , pp. 1480-1488
    • Thomas, D.L.1    Villano, S.A.2    Riester, K.A.3
  • 15
    • 0034718227 scopus 로고    scopus 로고
    • The natural history of hepatitis C virus infection: Host, viral, and environmental factors
    • Thomas DL, Astemborski J, Rai RM, et al. 2000. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284:450-56
    • (2000) JAMA , vol.284 , pp. 450-456
    • Thomas, D.L.1    Astemborski, J.2    Rai, R.M.3
  • 16
    • 0037181727 scopus 로고    scopus 로고
    • Protection against persistence of hepatitis C
    • Mehta SH, Cox A, Hoover DR, et al. 2002. Protection against persistence of hepatitis C. Lancet 359:1478-83
    • (2002) Lancet , vol.359 , pp. 1478-1483
    • Mehta, S.H.1    Cox, A.2    Hoover, D.R.3
  • 17
    • 0029791087 scopus 로고    scopus 로고
    • Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users
    • Thomas DL, Shih JW, Alter HJ, et al. 1996. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J. Infect. Dis. 174:690-95
    • (1996) J. Infect. Dis , vol.174 , pp. 690-695
    • Thomas, D.L.1    Shih, J.W.2    Alter, H.J.3
  • 18
    • 0036721470 scopus 로고    scopus 로고
    • End-stage liver disease in persons with hemophilia and transfusion-associated infections
    • Goedert JJ, Eyster ME, Lederman MM, et al. 2002. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 100:1584-89
    • (2002) Blood , vol.100 , pp. 1584-1589
    • Goedert, J.J.1    Eyster, M.E.2    Lederman, M.M.3
  • 19
    • 0028129404 scopus 로고
    • Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease
    • Eyster ME, Fried MW, Di Bisceglie AM, et al. 1994. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Blood 84:1020-23
    • (1994) Blood , vol.84 , pp. 1020-1023
    • Eyster, M.E.1    Fried, M.W.2    Di Bisceglie, A.M.3
  • 20
    • 0037183911 scopus 로고    scopus 로고
    • Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in coinfected subjects
    • Chung RT, Evans SR, Yang Y, et al. 2002. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in coinfected subjects. AIDS 16:1915-23
    • (2002) AIDS , vol.16 , pp. 1915-1923
    • Chung, R.T.1    Evans, S.R.2    Yang, Y.3
  • 21
    • 0035882187 scopus 로고    scopus 로고
    • Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis
    • Graham CS, Baden LR, Yu E, et al. 2001. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin. Infect. Dis. 33:562-69
    • (2001) Clin. Infect. Dis , vol.33 , pp. 562-569
    • Graham, C.S.1    Baden, L.R.2    Yu, E.3
  • 22
    • 0035112776 scopus 로고    scopus 로고
    • Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection
    • Bica I, McGovern B, Dhar R, et al. 2001. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin. Infect. Dis. 32:492-97
    • (2001) Clin. Infect. Dis , vol.32 , pp. 492-497
    • Bica, I.1    McGovern, B.2    Dhar, R.3
  • 23
    • 33846991954 scopus 로고    scopus 로고
    • Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)
    • Rosenthal E, Pialoux G, Bernard N, et al. 2007. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J. Viral Hepat. 14:183-88
    • (2007) J. Viral Hepat , vol.14 , pp. 183-188
    • Rosenthal, E.1    Pialoux, G.2    Bernard, N.3
  • 24
    • 85062055676 scopus 로고    scopus 로고
    • Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study
    • Weber R, Sabin CA, Friis-Moller N, et al. 2006. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch. Intern. Med. 166:1632-41
    • (2006) Arch. Intern. Med , vol.166 , pp. 1632-1641
    • Weber, R.1    Sabin, C.A.2    Friis-Moller, N.3
  • 25
    • 33846904554 scopus 로고    scopus 로고
    • Survival of persons with and without HIV infection in Denmark, 1995-2005
    • Lohse N, Hansen AB, Pedersen G, et al. 2007. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann. Intern. Med. 146:87-95
    • (2007) Ann. Intern. Med , vol.146 , pp. 87-95
    • Lohse, N.1    Hansen, A.B.2    Pedersen, G.3
  • 26
    • 33749175714 scopus 로고    scopus 로고
    • Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City
    • Sackoff JE, Hanna DB, Pfeiffer MR, et al. 2006. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann. Intern. Med. 145:397-406
    • (2006) Ann. Intern. Med , vol.145 , pp. 397-406
    • Sackoff, J.E.1    Hanna, D.B.2    Pfeiffer, M.R.3
  • 27
    • 0034679085 scopus 로고    scopus 로고
    • Elevated liver enzymes following initiation of antiretroviral therapy
    • Sulkowski MS, Thomas DL, Chaisson RE, et al. 2000. Elevated liver enzymes following initiation of antiretroviral therapy. JAMA 283:2526-27
    • (2000) JAMA , vol.283 , pp. 2526-2527
    • Sulkowski, M.S.1    Thomas, D.L.2    Chaisson, R.E.3
  • 28
    • 33746059779 scopus 로고    scopus 로고
    • Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients
    • McGovern BH, Ditelberg JS, Taylor LE, et al. 2006. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin. Infect. Dis. 43:365-72
    • (2006) Clin. Infect. Dis , vol.43 , pp. 365-372
    • McGovern, B.H.1    Ditelberg, J.S.2    Taylor, L.E.3
  • 29
    • 0029052336 scopus 로고
    • Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: Case report and literature review
    • Khella SL, Frost S, Hermann GA, et al. 1995. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review. Neurology 45:407-11
    • (1995) Neurology , vol.45 , pp. 407-411
    • Khella, S.L.1    Frost, S.2    Hermann, G.A.3
  • 30
    • 0032837102 scopus 로고    scopus 로고
    • Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group
    • Benhamou Y, Bochet M, Di Martino V, et al. 1999. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30:1054-58
    • (1999) Hepatology , vol.30 , pp. 1054-1058
    • Benhamou, Y.1    Bochet, M.2    Di Martino, V.3
  • 31
    • 28844509556 scopus 로고    scopus 로고
    • Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy
    • Brau N, Salvatore M, Rios-Bedoya CF, et al. 2006. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J. Hepatol. 44:47-55
    • (2006) J. Hepatol , vol.44 , pp. 47-55
    • Brau, N.1    Salvatore, M.2    Rios-Bedoya, C.F.3
  • 32
    • 0344120830 scopus 로고    scopus 로고
    • Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C coinfection
    • Qurishi N, Kreuzberg C, Luchters G, et al. 2004. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C coinfection. Lancet 362:1708-13
    • (2004) Lancet , vol.362 , pp. 1708-1713
    • Qurishi, N.1    Kreuzberg, C.2    Luchters, G.3
  • 33
    • 1842479859 scopus 로고    scopus 로고
    • Diagnosis, management, and treatment of hepatitis C
    • Strader DB, Wright T, Thomas DL, et al. 2004. Diagnosis, management, and treatment of hepatitis C. Hepatology 39:1147-71
    • (2004) Hepatology , vol.39 , pp. 1147-1171
    • Strader, D.B.1    Wright, T.2    Thomas, D.L.3
  • 34
    • 20144389653 scopus 로고    scopus 로고
    • Alberti A, Clumeck N, Collins S, et al. 2005. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV-coinfected patients. J. Hepatol. 42:615-24
    • Alberti A, Clumeck N, Collins S, et al. 2005. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV-coinfected patients. J. Hepatol. 42:615-24
  • 35
    • 0033058754 scopus 로고    scopus 로고
    • Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon
    • Reichard O, Glaumann H, Fryden A, et al. 1999. Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon. J. Hepatol. 30:783-87
    • (1999) J. Hepatol , vol.30 , pp. 783-787
    • Reichard, O.1    Glaumann, H.2    Fryden, A.3
  • 36
    • 11144252248 scopus 로고    scopus 로고
    • Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies
    • Soriano V, Maida I, Nunez M, et al. 2004. Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies. Antivir. Ther. 9:987-92
    • (2004) Antivir. Ther , vol.9 , pp. 987-992
    • Soriano, V.1    Maida, I.2    Nunez, M.3
  • 37
    • 33646895462 scopus 로고    scopus 로고
    • Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients
    • Dominguez S, Ghosn J, Valantin MA, et al. 2006. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. AIDS 20:1157-61
    • (2006) AIDS , vol.20 , pp. 1157-1161
    • Dominguez, S.1    Ghosn, J.2    Valantin, M.A.3
  • 38
    • 10344230440 scopus 로고    scopus 로고
    • Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial
    • Carrat F, Bani-Sadr F, Pol S, et al. 2004. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292:2839-48
    • (2004) JAMA , vol.292 , pp. 2839-2848
    • Carrat, F.1    Bani-Sadr, F.2    Pol, S.3
  • 39
    • 3343012408 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
    • Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. 2004. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N. Engl. J. Med. 351:438-50
    • (2004) N. Engl. J. Med , vol.351 , pp. 438-450
    • Torriani, F.J.1    Rodriguez-Torres, M.2    Rockstroh, J.K.3
  • 40
    • 3342892905 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin vs interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
    • Chung RT, Andersen J, Volberding P, et al. 2004. Peginterferon alfa-2a plus ribavirin vs interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N. Engl. J. Med. 351:451-59
    • (2004) N. Engl. J. Med , vol.351 , pp. 451-459
    • Chung, R.T.1    Andersen, J.2    Volberding, P.3
  • 41
    • 4444270265 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV coinfected patients
    • Laguno M, Murillas J, Blanco JL, et al. 2004. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV coinfected patients. AIDS 18:F27-36
    • (2004) AIDS , vol.18
    • Laguno, M.1    Murillas, J.2    Blanco, J.L.3
  • 42
    • 1542378867 scopus 로고    scopus 로고
    • Peginterferon- alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose
    • Hadziyannis SJ, Sette H Jr., Morgan TR, et al. 2004. Peginterferon- alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 140:346-55
    • (2004) Ann. Intern. Med , vol.140 , pp. 346-355
    • Hadziyannis, S.J.1    Sette Jr., H.2    Morgan, T.R.3
  • 43
    • 33750587348 scopus 로고    scopus 로고
    • Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus coinfection
    • Lissen E, Clumeck N, Sola R, et al. 2006. Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus coinfection. AIDS 20:2175-81
    • (2006) AIDS , vol.20 , pp. 2175-2181
    • Lissen, E.1    Clumeck, N.2    Sola, R.3
  • 44
    • 3343006133 scopus 로고    scopus 로고
    • Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy
    • Mauss S, Valenti W, Depamphilis J, et al. 2004. Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. AIDS 18:F21-25
    • (2004) AIDS , vol.18
    • Mauss, S.1    Valenti, W.2    Depamphilis, J.3
  • 45
    • 33748751179 scopus 로고    scopus 로고
    • Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons
    • Alvarez D, Dieterich DT, Brau N, et al. 2006. Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons. J. Viral Hepat. 13:683-89
    • (2006) J. Viral Hepat , vol.13 , pp. 683-689
    • Alvarez, D.1    Dieterich, D.T.2    Brau, N.3
  • 46
    • 0035956691 scopus 로고    scopus 로고
    • Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
    • Lafeuillade A, Hittinger G, Chadapaud S. 2001. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. Lancet 357:280-81
    • (2001) Lancet , vol.357 , pp. 280-281
    • Lafeuillade, A.1    Hittinger, G.2    Chadapaud, S.3
  • 47
    • 0037340278 scopus 로고    scopus 로고
    • Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease
    • Neff GW, Bonham A, Tzakis AG, et al. 2003. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl. 9:239-47
    • (2003) Liver Transpl , vol.9 , pp. 239-247
    • Neff, G.W.1    Bonham, A.2    Tzakis, A.G.3
  • 48
    • 33751225955 scopus 로고    scopus 로고
    • Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic
    • Mehta SH, Lucas GM, Mirel LB, et al. 2006. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS 20:2361-69
    • (2006) AIDS , vol.20 , pp. 2361-2369
    • Mehta, S.H.1    Lucas, G.M.2    Mirel, L.B.3
  • 49
    • 0028818269 scopus 로고
    • Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR
    • Lanford RE, Chavez D, Von Chisari F, et al. 1995. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J. Virol. 69:8079-83
    • (1995) J. Virol , vol.69 , pp. 8079-8083
    • Lanford, R.E.1    Chavez, D.2    Von Chisari, F.3
  • 50
    • 0142178211 scopus 로고    scopus 로고
    • HCV persistence and immune evasion in the absence of memory T cell help
    • Grakoui A, Shoukry NH, Woollard DJ, et al. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659-62
    • (2003) Science , vol.302 , pp. 659-662
    • Grakoui, A.1    Shoukry, N.H.2    Woollard, D.J.3
  • 51
    • 19944432793 scopus 로고    scopus 로고
    • The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1
    • Kim AY, Lauer GM, Ouchi K, et al. 2005. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood 105:1170-78
    • (2005) Blood , vol.105 , pp. 1170-1178
    • Kim, A.Y.1    Lauer, G.M.2    Ouchi, K.3
  • 52
    • 33845896269 scopus 로고    scopus 로고
    • Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection
    • Kim AY, Schulze zur WJ, Kuntzen T, et al. 2006. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med. 3:e492
    • (2006) PLoS Med , vol.3
    • Kim, A.Y.1    Schulze zur, W.J.2    Kuntzen, T.3
  • 53
    • 33847686361 scopus 로고    scopus 로고
    • CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection
    • Netski DM, Mosbruger T, Astemborski J, et al. 2007. CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection. J. Infect. Dis. 195:857-63
    • (2007) J. Infect. Dis , vol.195 , pp. 857-863
    • Netski, D.M.1    Mosbruger, T.2    Astemborski, J.3
  • 54
    • 33748077787 scopus 로고    scopus 로고
    • Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes
    • Balasubramanian A, Ganju RK, Groopman JE. 2006. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. J. Infect. Dis. 194:670-81
    • (2006) J. Infect. Dis , vol.194 , pp. 670-681
    • Balasubramanian, A.1    Ganju, R.K.2    Groopman, J.E.3
  • 55
    • 34249098017 scopus 로고    scopus 로고
    • Viral factors associated with cytokine expression during HCV/HIV co-infection
    • Blackard JT, Kang M, Clair JB, et al. 2007. Viral factors associated with cytokine expression during HCV/HIV co-infection. J. Interferon Cytokine Res. 27:263-70
    • (2007) J. Interferon Cytokine Res , vol.27 , pp. 263-270
    • Blackard, J.T.1    Kang, M.2    Clair, J.B.3
  • 56
    • 0034715950 scopus 로고    scopus 로고
    • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study
    • Greub G, Ledergerber B, Battegay M, et al. 2000. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 356:1800-5
    • (2000) Lancet , vol.356 , pp. 1800-1805
    • Greub, G.1    Ledergerber, B.2    Battegay, M.3
  • 57
    • 0037055011 scopus 로고    scopus 로고
    • Hepatitis C and progression of HIV disease
    • Sulkowski MS, Moore RD, Mehta SH, et al. 2002. Hepatitis C and progression of HIV disease. JAMA 288:199-206
    • (2002) JAMA , vol.288 , pp. 199-206
    • Sulkowski, M.S.1    Moore, R.D.2    Mehta, S.H.3
  • 58
    • 0036333636 scopus 로고    scopus 로고
    • Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system
    • Contreras AM, Hiasa Y, He W, et al. 2002. Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J. Virol. 76:8505-17
    • (2002) J. Virol , vol.76 , pp. 8505-8517
    • Contreras, A.M.1    Hiasa, Y.2    He, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.